Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
15.75
-0.04 (-0.25%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Eton Pharmaceuticals Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Eton Pharmaceuticals stock have an average target of 27.67, with a low estimate of 24 and a high estimate of 33. The average target predicts an increase of 75.68% from the current stock price of 15.75.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 19, 2025.
Analyst Ratings
The average analyst rating for Eton Pharmaceuticals stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $23 → $26 | Strong Buy | Maintains | $23 → $26 | +65.08% | Mar 19, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $21 → $24 | Strong Buy | Reiterates | $21 → $24 | +52.38% | Mar 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $33 | Strong Buy | Reiterates | $33 | +109.52% | Mar 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $17 → $33 | Strong Buy | Maintains | $17 → $33 | +109.52% | Jan 23, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Initiates $21 | Strong Buy | Initiates | $21 | +33.33% | Jan 10, 2025 |
Financial Forecast
Revenue This Year
75.03M
from 39.01M
Increased by 92.33%
Revenue Next Year
114.51M
from 75.03M
Increased by 52.62%
EPS This Year
0.41
from -0.15
EPS Next Year
1.24
from 0.41
Increased by 204.17%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 82.0M | 123.0M | 175.3M | ||
| Avg | 75.0M | 114.5M | 158.5M | ||
| Low | 68.6M | 100.7M | 140.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 110.3% | 63.9% | 53.1% | ||
| Avg | 92.3% | 52.6% | 38.4% | ||
| Low | 75.8% | 34.1% | 23.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 0.46 | 1.65 | 1.94 | ||
| Avg | 0.41 | 1.24 | 1.68 | ||
| Low | 0.33 | 0.98 | 1.42 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 304.0% | 56.5% | ||
| Avg | - | 204.2% | 35.6% | ||
| Low | - | 140.2% | 14.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.